KAWAS LEEN 13D/13G Filings for Athira Pharma, Inc. (ATHA)

KAWAS LEEN 13D and 13G filings for Athira Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-16
06:03 am
Purchase
2020-12-31 13G Athira Pharma, Inc.
ATHA
KAWAS LEEN 1,693,102
5.200%
1,693,102increase
(New Position)
Filing